#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Essential thrombocythaemia Rhabdoid tumour Philadelphia positive acute lymphocytic leukaemia Malignant oligodendroglioma Extra-osseous Ewing's sarcoma metastatic Oesophageal adenocarcinoma stage III Complex regional pain syndrome Anti-HLA antibody test positive Chronic kidney disease Factor IX deficiency Transitional cell cancer of the renal pelvis and ureter Acute lymphocytic leukaemia Infective uveitis Chondrosarcoma Neuroendocrine carcinoma More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III Hairy cell leukaemia recurrent – Basic Information Friedreich’s ataxia – Trials in Disease Gaucher’s disease type III Progressive multifocal leukoencephalopathy – Life with Disease Sarcoidosis Mast cell activation syndrome – Trials in Disease Nodal marginal zone B-cell lymphoma Rhabdomyosarcoma recurrent Aicardi-Goutieres syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tozorakimab Menotrophin Birtamimab Tetrahydrouridine Glycopyrronium Bromide Sodium Glycerophosphate M2Rlab Murcidencel Etelcalcetide [18F]Fapi-74 Db-Oto-3 HALOBETASOL PROPIONATE Daplusiran L-SERINE Exidavnemab Ibuprofen Arginine Mps-102 Dersimelagon Phosphate Prax-628 Rbl027.2 More therapies…

    Learn about Your Condition

    Scoliosis Acute leukaemia Renal disorder Vulvovaginal dryness Joint stabilisation EGFR gene mutation Cardiac ventricular thrombosis Patent ductus arteriosus Mantle cell lymphoma stage III Optic ischaemic neuropathy Stem cell transplant Autoimmune haemolytic anaemia Hyperinsulinism Pancreatitis relapsing Malignant melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Atypical Teratoid/Rhabdoid Tumors in Children Using Dactinomycin, Carboplatin, and Cyclophosphamide

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atypical teratoid/rhabdoid tumour of CNS
    Investigated Drugs:
    • Dactinomycin
    • Ifosfamide
    • Methotrexate
    Belgium Czechia Denmark Finland France Germany +6

  • Study on the Safety and Effectiveness of VB10.16 and Pembrolizumab for Patients with HPV16-Positive Head and Neck Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Vb10.16
    • Pembrolizumab
    Czechia France Germany Hungary Norway Poland +1

  • Study on the Safety and Effect of EXOB-001 in Preventing Bronchopulmonary Dysplasia in Extremely Preterm Newborns

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    Investigated Drugs:
    • Allogeneic Umbilical Cord Mesenchymal Cells-Derived Extracellular Vesicles
    • Sodium Chloride
    Belgium Italy

  • Study on Sodium Phenylbutyrate for Improving Blood Sugar Control in Type 2 Diabetes Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Sodium Phenylbutyrate
    The Netherlands

  • Study Comparing 177Lu-Edotreotide and Everolimus for Patients with Neuroendocrine Tumors in the Lung and Thymus

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Lutetium (177Lu) Edotreotide
    • Everolimus
    • L-Arginine Hydrochloride
    Belgium France Italy Spain

  • Study on Nipocalimab for Children Aged 2-17 with Generalized Myasthenia Gravis

    Recruiting

    4 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Nipocalimab
    The Netherlands Poland
Previous Page
1 … 594 595 596 597 598 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!